Galectin Therapeutics (GALT) Current Leases (2020 - 2026)
Galectin Therapeutics (GALT) recorded quarterly Current Leases of $6000.0 in Q1 2026, down 72.73% quarter-over-quarter from $22000.0 in Q4 2025, and down 91.18% on a YoY basis from $68000.0 in Q1 2025.
Galectin Therapeutics (GALT) Current Leases (2020 - 2026) Analysis & Trends
Galectin Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $6000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 91.18% year-over-year to $6000.0; the TTM figure through Mar 2026 stood at $6000.0 (down 91.18% YoY), while the FY2025 annual figure was $22000.0, up 15.79% from the prior year.
- Current Leases was $6000.0 for Q1 2026 at Galectin Therapeutics, down from $22000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $68000.0 in Q1 2025 to a low of $6000.0 in Q1 2026.
- Historically, Current Leases has averaged $36764.7 across 5 years, with a median of $40000.0 in 2022.
- The sharpest annual moves came in 2022 and 2026: Current Leases soared 400.0% in 2022, then plunged 91.18% in 2026.
- A 5-year view of Current Leases shows it stood at $40000.0 in 2022, then increased by 15.0% to $46000.0 in 2023, then slumped by 58.7% to $19000.0 in 2024, then advanced by 15.79% to $22000.0 in 2025, then tumbled by 72.73% to $6000.0 in 2026.
- The last three Current Leases figures came in at $6000.0 (Q1 2026), $22000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Dec 31, 2020 | 44,000.00 |